Core 3: Biostatistics, Bioinformatics & Data Management (BBD) SUMMARY/ABSTRACT The overall goal of Core 3, the Biostatistics, Bioinformatics and Data Management (BBD) Core, is to provide comprehensive support in the areas of biostatistics, bioinformatics, and data management for all research Projects, Developmental Research and Career Enhancement programs, and Cores in the UCLA SPORE in Brain Cancer. The BBD Core is comprised of multiple faculty members from the departments of Biostatistics, Biomathematics, Molecular, Cell, & Developmental Biology (MCDB), and the UCLA Institute of Quantitative & Computational Biosciences (QCB), as well as staff statisticians, database managers, bioinformaticians, database and applications development programmers, and web designers. Faculty members include nationally respected biostatisticians and bioinformaticians with broad expertise in general biostatistics, design and analysis of clinical trials, analysis and interpretation of high-dimensional tissue arrays and gene expression data, and next generation sequencing (NGS) data analysis and management, which are needed by the SPORE research projects. Collectively and individually, the members have participated in hundreds of studies involving diverse aspects of cancer research, especially translational research. They have experience working in large centers and have served on multiple NIH study sections and review committees. The Core?s biostatistics/bioinformatics faculty and staff are actively involved in UCLA Jonsson Comprehensive Cancer Center (JCCC) current projects and have an established a history of productive collaborations with many researchers in this proposed SPORE. The BBD Core works closely with the UCLA SPORE in Brain Cancer investigators to provide input on study design, statistical analysis plans, bioinformatics, data management issues.

Public Health Relevance

Core 3: Biostatistics, Bioinformatics & Data Management (BBD) NARRATIVE The BBD Core aims to foster an outstanding environment in which to conduct translational research in brain cancer by providing the UCLA SPORE in Brain Cancer investigators with leading edge biostatistics, bioinformatics and data management support for all research Projects, the Developmental Research and Career Enhancement programs, and other Cores of the SPORE. Having the breadth of expertise readily available will facilitate the rigor and efficiency for SPORE projects. It is an indispensible shared resource central to the success of the SPORE studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA211015-04
Application #
9983046
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2017-08-11
Project End
2022-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kong, Xiao-Tang; Nguyen, Nhung T; Choi, Yoon J et al. (2018) Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 100:1195-1203
Olar, Adriana; Goodman, Lindsey D; Wani, Khalida M et al. (2018) A gene expression signature predicts recurrence-free survival in meningioma. Oncotarget 9:16087-16098
Lillehei, Kevin O; Kalkanis, Steven N; Liau, Linda M et al. (2018) Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry. CNS Oncol 7:CNS08
Calais, Jeremie; Fendler, Wolfgang P; Eiber, Matthias et al. (2018) Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence. J Nucl Med 59:434-441
Ohashi, Minori; Korsakova, Elena; Allen, Denise et al. (2018) Loss of MECP2 Leads to Activation of P53 and Neuronal Senescence. Stem Cell Reports 10:1453-1463
Goode, Benjamin; Mondal, Gourish; Hyun, Michael et al. (2018) A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle. Nat Commun 9:810
Patel, Chirag B; Fazzari, Elisa; Chakhoyan, Ararat et al. (2018) 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol 139:399-409
Davidson, Tom B; Lee, Alexander H; Hsu, Melody et al. (2018) Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation. Clin Cancer Res :
Harris, Robert J; Yao, Jingwen; Chakhoyan, Ararat et al. (2018) Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med 80:1962-1978
Zheng, Feibi; Zhou, Hui; Li, Ning et al. (2018) Skeletal effects of failed parathyroidectomy. Surgery 163:17-21

Showing the most recent 10 out of 91 publications